Food and Drug Administration approval to use the drug Enbrel
to treat psoriasis.
BOSTON -- Amgen (NASDAQ:AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), today announced that data from a multicenter, randomized, double-blind trial of ENBREL
plus methotrexate showed that 50 percent of patients with active early rheumatoid arthritis achieved clinical remission at one year.
THOUSAND OAKS - Biotechnology giant Amgen said Tuesday that a Food and Drug Administration panel recommended its drug Enbrel
for approval to treat spinal arthritis.
is the only biologic medicine currently approved to treat the signs and symptoms of JRA in patients who have previously tried a traditional disease modifying antirheumatic drug (DMARD).
said Friday that recent data proved its Enbrel
drug, in combination with cancer combatant methotrexate, was effective in treating rheumatoid arthritis.
(etanercept) is a soluble tumour necrosis factor which has potential in several inflammatory diseases mediated by excess TNF.
Morgan Stanley analyst Matthew Harrison noted that on Friday the USPTO's Patent Trial and Appeal Board denied the institution of two IPRs filed by Coherus Biosciences (CHRS) against Enbrel
patients 8,063,182 and 8,163,522, which he said removes one near-term overhang on Amgen (AMGN) shares.
In 1998, when the RA drug Enbrel
came to market, she was one of the first in Maine to try it.
Amgen has released Enbrel
Mini with AutoTouch in the United States.
The drugs include AbbVie's (NYSE: ABBV) Humira (adalimumab), Pfizer's (NYSE: PFE) Enbrel
(etanercept) and Janssen's Stelara (ustekinumab).
The prescribing information includes a boxed warning about the risk of serious infections associated with its use; that boxed warning also includes a statement that lymphoma and other malignancies, "some fatal, have been reported in children and adolescent patients treated with TNF blockers, including Enbrel
to provide fill-finish production services for the commercial supply of SB4, a biosimilar referencing Enbrel
(etanercept), which is used to treat rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis and plaque psoriasis.